Global incidence and prevalence of nonalcoholic fatty liver disease
Nonalcoholic fatty liver disease (NAFLD) is a leading cause of liver disease worldwide. The estimated global incidence of NAFLD is 47 cases per 1,000 population and is higher among males than females. The estimated global prevalence of NAFLD among adults is 32% and is higher among males (40%) compar...
| Main Authors: | , , , , , , , , |
|---|---|
| Format: | Article |
| Language: | English |
| Published: |
Korean Association for the Study of the Liver
2023-02-01
|
| Series: | Clinical and Molecular Hepatology |
| Subjects: | |
| Online Access: | http://e-cmh.org/upload/pdf/cmh-2022-0365.pdf |
| _version_ | 1797871543680761856 |
|---|---|
| author | Margaret LP Teng Cheng Han Ng Daniel Q. Huang Kai En Chan Darren JH Tan Wen Hui Lim Ju Dong Yang Eunice Tan Mark D. Muthiah |
| author_facet | Margaret LP Teng Cheng Han Ng Daniel Q. Huang Kai En Chan Darren JH Tan Wen Hui Lim Ju Dong Yang Eunice Tan Mark D. Muthiah |
| author_sort | Margaret LP Teng |
| collection | DOAJ |
| description | Nonalcoholic fatty liver disease (NAFLD) is a leading cause of liver disease worldwide. The estimated global incidence of NAFLD is 47 cases per 1,000 population and is higher among males than females. The estimated global prevalence of NAFLD among adults is 32% and is higher among males (40%) compared to females (26%). The global prevalence of NAFLD has increased over time, from 26% in studies from 2005 or earlier to 38% in studies from 2016 or beyond. The prevalence of NAFLD varies substantially by world region, contributed by differing rates of obesity, and genetic and socioeconomic factors. The prevalence of NAFLD exceeds 40% in the Americas and South-East Asia. The prevalence of NAFLD is projected to increase significantly in multiple world regions by 2030 if current trends are left unchecked. In this review, we discuss trends in the global incidence and prevalence of NAFLD and discuss future projections. |
| first_indexed | 2024-04-10T00:45:32Z |
| format | Article |
| id | doaj.art-e44ff4afd6e54a47aa472435c3d90f2b |
| institution | Directory Open Access Journal |
| issn | 2287-2728 2287-285X |
| language | English |
| last_indexed | 2024-04-10T00:45:32Z |
| publishDate | 2023-02-01 |
| publisher | Korean Association for the Study of the Liver |
| record_format | Article |
| series | Clinical and Molecular Hepatology |
| spelling | doaj.art-e44ff4afd6e54a47aa472435c3d90f2b2023-03-14T01:46:51ZengKorean Association for the Study of the LiverClinical and Molecular Hepatology2287-27282287-285X2023-02-0129SupplS32S4210.3350/cmh.2022.03651748Global incidence and prevalence of nonalcoholic fatty liver diseaseMargaret LP Teng0Cheng Han Ng1Daniel Q. Huang2Kai En Chan3Darren JH Tan4Wen Hui Lim5Ju Dong Yang6Eunice Tan7Mark D. Muthiah8 Division of Gastroenterology and Hepatology, Department of Medicine, National University Hospital, Singapore Yong Loo Lin School of Medicine, National University of Singapore, Singapore Division of Gastroenterology and Hepatology, Department of Medicine, National University Hospital, Singapore Yong Loo Lin School of Medicine, National University of Singapore, Singapore Yong Loo Lin School of Medicine, National University of Singapore, Singapore Yong Loo Lin School of Medicine, National University of Singapore, Singapore Karsh Division of Gastroenterology and Hepatology, Cedars-Sinai Medical Center, Los Angeles, CA, USA Division of Gastroenterology and Hepatology, Department of Medicine, National University Hospital, Singapore Division of Gastroenterology and Hepatology, Department of Medicine, National University Hospital, SingaporeNonalcoholic fatty liver disease (NAFLD) is a leading cause of liver disease worldwide. The estimated global incidence of NAFLD is 47 cases per 1,000 population and is higher among males than females. The estimated global prevalence of NAFLD among adults is 32% and is higher among males (40%) compared to females (26%). The global prevalence of NAFLD has increased over time, from 26% in studies from 2005 or earlier to 38% in studies from 2016 or beyond. The prevalence of NAFLD varies substantially by world region, contributed by differing rates of obesity, and genetic and socioeconomic factors. The prevalence of NAFLD exceeds 40% in the Americas and South-East Asia. The prevalence of NAFLD is projected to increase significantly in multiple world regions by 2030 if current trends are left unchecked. In this review, we discuss trends in the global incidence and prevalence of NAFLD and discuss future projections.http://e-cmh.org/upload/pdf/cmh-2022-0365.pdfnonalcoholic fatty liver diseaseincidenceprevalenceepidemiology |
| spellingShingle | Margaret LP Teng Cheng Han Ng Daniel Q. Huang Kai En Chan Darren JH Tan Wen Hui Lim Ju Dong Yang Eunice Tan Mark D. Muthiah Global incidence and prevalence of nonalcoholic fatty liver disease Clinical and Molecular Hepatology nonalcoholic fatty liver disease incidence prevalence epidemiology |
| title | Global incidence and prevalence of nonalcoholic fatty liver disease |
| title_full | Global incidence and prevalence of nonalcoholic fatty liver disease |
| title_fullStr | Global incidence and prevalence of nonalcoholic fatty liver disease |
| title_full_unstemmed | Global incidence and prevalence of nonalcoholic fatty liver disease |
| title_short | Global incidence and prevalence of nonalcoholic fatty liver disease |
| title_sort | global incidence and prevalence of nonalcoholic fatty liver disease |
| topic | nonalcoholic fatty liver disease incidence prevalence epidemiology |
| url | http://e-cmh.org/upload/pdf/cmh-2022-0365.pdf |
| work_keys_str_mv | AT margaretlpteng globalincidenceandprevalenceofnonalcoholicfattyliverdisease AT chenghanng globalincidenceandprevalenceofnonalcoholicfattyliverdisease AT danielqhuang globalincidenceandprevalenceofnonalcoholicfattyliverdisease AT kaienchan globalincidenceandprevalenceofnonalcoholicfattyliverdisease AT darrenjhtan globalincidenceandprevalenceofnonalcoholicfattyliverdisease AT wenhuilim globalincidenceandprevalenceofnonalcoholicfattyliverdisease AT judongyang globalincidenceandprevalenceofnonalcoholicfattyliverdisease AT eunicetan globalincidenceandprevalenceofnonalcoholicfattyliverdisease AT markdmuthiah globalincidenceandprevalenceofnonalcoholicfattyliverdisease |